Daily Judi: Friday, September 2, 2022
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
According to trademark document research, big box retailer Walmart has sights on the scientific research, technology, and clinical trial business. Insider Intelligence points out that because of Walmart's locations across America, this could lead to more diversity in clinical trials.
While Medtronic awaits FDA approval for its MiniMed 780G insulin pump, which has been available in Europe for two years, the company announced study results that for patients with Type 1 diabetes, its system adds 27% boost to time in target blood sugar (blood glucose) range. (Fierce Biotech)
Meanwhile, at Clinical Leader, industry veteran Penelope Przekop, MSQA, RQAP-GCP, discusses strategies to conduct a clinical trial with moral integrity.
The CNS Summit 2022 will be held on November 17–20, in Boca Raton, Florida. Created as "a community of innovators and industry leaders who are not afraid to challenge the status quo," CNS was founded in 2009 to advance clinical development, focused on collaboration and innovation. Team Judi will be there!
We also hope to see you this September 13-14, in Boston, for DPHARM: Disruptive Innovations to Advance Clinical Trials, walking distance from our North End headquarters.
“We work proactively with each client, analyzing our reports to make them work faster, to help make our client’s life better.”
–Tim, Trial Delivery
Judi empowers and enhances the world's clinical trial ecosystems. Our cloud-based platform has 110,000 users across 140 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.